Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01929954 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Gintuit™ in Subjects Requiring Socket Grafting
A Phase 1 study, sponsored by Organogenesis.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01929954 is a Phase 1 study that was terminated before completion, run by Organogenesis. The registered enrollment target is 5 participants.
The verdict
NCT01929954, a Phase 1 study, was terminated before completion, sponsored by Organogenesis.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a prospective, randomized, controlled, parallel group Phase 1/2 assessment of the safety of GINTUIT versus Bio-Gide in subjects who have a posterior tooth requiring extraction. The incidence and severity of adverse events will be summarized by group (GINTUIT and Bio-Gide).
Interventions
- BIOLOGICAL Gintuit
- DEVICE Bio-Gide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01929954
The ClinicalTrials.gov registry entry for NCT01929954 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gintuit is the first listed.
NCT01929954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01929954 about?
NCT01929954 is a clinical study titled "Safety Study of Gintuit™ in Subjects Requiring Socket Grafting". This is a prospective, randomized, controlled, parallel group Phase 1/2 assessment of the safety of GINTUIT versus Bio-Gide in subjects who have a posterior tooth requiring extraction. The incidence and severity of adverse events will be summarized by group (GINTUIT and Bio-Gide).
What is the current status of trial NCT01929954?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2013-07. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01929954?
The interventions under investigation include: Gintuit (BIOLOGICAL), Bio-Gide (DEVICE).
Who is sponsoring clinical trial NCT01929954?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.